Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::404367469.png) @EgidiusLambrech E Lambrechts

E Lambrechts posts on X about $gmab, $mrus, combo, $jnj the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::404367469/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:interactions.svg)

- X Week XXXXX +311%
- X Month XXXXX +37%
- X Months XXXXXX -XX%
- X Year XXXXXX -XXXX%

### Mentions: X [#](/creator/twitter::404367469/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:posts_active.svg)

- X Week XX +38%
- X Month XX +94%
- X Months XX +24%
- X Year XXX +38%

### Followers: XXX [#](/creator/twitter::404367469/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:followers.svg)

- X Week XXX +0.29%
- X Month XXX -XXXX%
- X Months XXX +3%
- X Year XXX -XX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::404367469/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::404367469/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX%

**Social topic influence**
[$gmab](/topic/$gmab) #13, [$mrus](/topic/$mrus) 5.71%, [combo](/topic/combo) 5.71%, [$jnj](/topic/$jnj) #315, [mono](/topic/mono) 2.86%, [promising](/topic/promising) 2.86%, [hc](/topic/hc) XXXX%

**Top accounts mentioned or mentioned by**
[@streetinsider](/creator/undefined) [@ekleemd](/creator/undefined) [@danafarber](/creator/undefined) [@genmab](/creator/undefined) [@fyee0308](/creator/undefined) [@abdallah81md](/creator/undefined) [@janssenglobal](/creator/undefined) [@sanofi](/creator/undefined) [@bmsnews](/creator/undefined) [@amgen](/creator/undefined) [@davidmygind](/creator/undefined) [@cision](/creator/undefined) [@bertrandbio](/creator/undefined)

**Top assets mentioned**
[Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Johnson & Johnson (JNJ)](/topic/$jnj)
### Top Social Posts [#](/creator/twitter::404367469/posts)
---
Top posts by engagements in the last XX hours

"Is #Genmabs New Asset the Next Big Bet in PD-1 Combination Therapy for Head and Neck Cancer Petosemtamab EGFRLGR5 $GMAB"  
[X Link](https://x.com/EgidiusLambrech/status/1973304416603349316) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-01T08:30Z XXX followers, XXX engagements


"#Merus Announces #Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics $GMAB #Genmab"  
[X Link](https://x.com/EgidiusLambrech/status/1977775373044556257) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-13T16:36Z XXX followers, XXX engagements


"#Merus Announces Publication of an Abstract on #Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics -very early data more on October XX $GMAB #Genmab"  
[X Link](https://x.com/EgidiusLambrech/status/1978082136696455488) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-14T12:55Z XXX followers, XX engagements


"$GMAB #Genmab"  
[X Link](https://x.com/EgidiusLambrech/status/1978101436350108115) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-14T14:11Z XXX followers, XXX engagements


"Teclistamab $JNJ $GMAB #Genmab Tecvayli"  
[X Link](https://x.com/EgidiusLambrech/status/1978719238467493965) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-16T07:06Z XXX followers, XXX engagements


"#Petosemtamab shows first colorectal promise $MRUS $GMAB #Genmab"  
[X Link](https://x.com/EgidiusLambrech/status/1978722419754815886) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-16T07:19Z XXX followers, XXX engagements


"$GMAB #Genmab Tecvayli/Darzalex combo"  
[X Link](https://x.com/EgidiusLambrech/status/1978800685526474763) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-16T12:30Z XXX followers, XXX engagements


"Promising Clinical Developments in #Genmabs Portfolio Reinforce Buy Rating Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Genmab and keeping the price target at $XXXXX. $GMAB"  
[X Link](https://x.com/EgidiusLambrech/status/1980595729703002148) [@EgidiusLambrech](/creator/x/EgidiusLambrech) 2025-10-21T11:23Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@EgidiusLambrech Avatar @EgidiusLambrech E Lambrechts

E Lambrechts posts on X about $gmab, $mrus, combo, $jnj the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX +311%
  • X Month XXXXX +37%
  • X Months XXXXXX -XX%
  • X Year XXXXXX -XXXX%

Mentions: X #

Mentions Line Chart

  • X Week XX +38%
  • X Month XX +94%
  • X Months XX +24%
  • X Year XXX +38%

Followers: XXX #

Followers Line Chart

  • X Week XXX +0.29%
  • X Month XXX -XXXX%
  • X Months XXX +3%
  • X Year XXX -XX%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX%

Social topic influence $gmab #13, $mrus 5.71%, combo 5.71%, $jnj #315, mono 2.86%, promising 2.86%, hc XXXX%

Top accounts mentioned or mentioned by @streetinsider @ekleemd @danafarber @genmab @fyee0308 @abdallah81md @janssenglobal @sanofi @bmsnews @amgen @davidmygind @cision @bertrandbio

Top assets mentioned Merus N.V. Common Shares (MRUS) Johnson & Johnson (JNJ)

Top Social Posts #


Top posts by engagements in the last XX hours

"Is #Genmabs New Asset the Next Big Bet in PD-1 Combination Therapy for Head and Neck Cancer Petosemtamab EGFRLGR5 $GMAB"
X Link @EgidiusLambrech 2025-10-01T08:30Z XXX followers, XXX engagements

"#Merus Announces #Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics $GMAB #Genmab"
X Link @EgidiusLambrech 2025-10-13T16:36Z XXX followers, XXX engagements

"#Merus Announces Publication of an Abstract on #Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics -very early data more on October XX $GMAB #Genmab"
X Link @EgidiusLambrech 2025-10-14T12:55Z XXX followers, XX engagements

"$GMAB #Genmab"
X Link @EgidiusLambrech 2025-10-14T14:11Z XXX followers, XXX engagements

"Teclistamab $JNJ $GMAB #Genmab Tecvayli"
X Link @EgidiusLambrech 2025-10-16T07:06Z XXX followers, XXX engagements

"#Petosemtamab shows first colorectal promise $MRUS $GMAB #Genmab"
X Link @EgidiusLambrech 2025-10-16T07:19Z XXX followers, XXX engagements

"$GMAB #Genmab Tecvayli/Darzalex combo"
X Link @EgidiusLambrech 2025-10-16T12:30Z XXX followers, XXX engagements

"Promising Clinical Developments in #Genmabs Portfolio Reinforce Buy Rating Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Genmab and keeping the price target at $XXXXX. $GMAB"
X Link @EgidiusLambrech 2025-10-21T11:23Z XXX followers, XX engagements

@EgidiusLambrech
/creator/twitter::EgidiusLambrech